NCT01496183View on ClinicalTrials.gov

Metabolic Effects of Olanzapine in Healthy Males

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Healthy
Interventions
DRUG

Olanzapine

Olanzapine 5mg capsule administered orally at bedtime for 7 days followed by Olanzapine 10 mg capsule administered orally at bedtime for 7 days.

DRUG

Placebo

Placebo capsule administered orally at bedtime for 14 days

Trial Locations (1)

14215

Department of Psychiatry, The State University of New York at Buffalo, Buffalo

All Listed Sponsors
lead

State University of New York at Buffalo

OTHER

NCT01496183 - Metabolic Effects of Olanzapine in Healthy Males | Biotech Hunter | Biotech Hunter